眼内视网膜母细胞瘤:一个新的分组分类病例。

Ophthalmology clinics of North America Pub Date : 2005-03-01 DOI:10.1016/j.ohc.2004.11.003

A Linn Murphree

{"title":"眼内视网膜母细胞瘤:一个新的分组分类病例。","authors":"A Linn Murphree","doi":"10.1016/j.ohc.2004.11.003","DOIUrl":null,"url":null,"abstract":"This article argues the case for the creation of a new group classification of intraocular retinoblastoma. The current Reese-Ellsworth group classification has not been updated since it was published 35 years ago. The proposed classification is based on the natural history of intraocular retinoblastoma and on the risk of loss of the eye following primary therapy.","PeriodicalId":82231,"journal":{"name":"Ophthalmology clinics of North America","volume":"18 1","pages":"41-53, viii"},"PeriodicalIF":0.0000,"publicationDate":"2005-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ohc.2004.11.003","citationCount":"350","resultStr":"{\"title\":\"Intraocular retinoblastoma: the case for a new group classification.\",\"authors\":\"A Linn Murphree\",\"doi\":\"10.1016/j.ohc.2004.11.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This article argues the case for the creation of a new group classification of intraocular retinoblastoma. The current Reese-Ellsworth group classification has not been updated since it was published 35 years ago. The proposed classification is based on the natural history of intraocular retinoblastoma and on the risk of loss of the eye following primary therapy.\",\"PeriodicalId\":82231,\"journal\":{\"name\":\"Ophthalmology clinics of North America\",\"volume\":\"18 1\",\"pages\":\"41-53, viii\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ohc.2004.11.003\",\"citationCount\":\"350\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology clinics of North America\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ohc.2004.11.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology clinics of North America","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ohc.2004.11.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 350

摘要

这篇文章争论的情况下，创建一个新的组分类眼内视网膜母细胞瘤。目前的里斯-埃尔斯沃思分类自从35年前出版以来就没有更新过。提出的分类是基于眼内视网膜母细胞瘤的自然史和初次治疗后眼睛丧失的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Intraocular retinoblastoma: the case for a new group classification.

This article argues the case for the creation of a new group classification of intraocular retinoblastoma. The current Reese-Ellsworth group classification has not been updated since it was published 35 years ago. The proposed classification is based on the natural history of intraocular retinoblastoma and on the risk of loss of the eye following primary therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Ophthalmology clinics of North America

自引率

0.00%

发文量